STOK · Stoke Therapeutics, Inc.
AI read · Neutral
The AI's read
The change affects board membership, not Stoke's reported operations. Dr. Kaye also left the research and development committee, but the filing says his departure was not due to disagreement. An independent director filled the board vacancy. The filing lists annual cash pay and a stock option grant, but reports no change to Stoke's business prospects.